A patient w/ICM (LVEF 15%) p/w angina & DOE. SPECT shows a fixed defect & LHC shows LCx CTO.
...To revasc or not to revasc...
1st we need to know if the myocardium is dead or alive?! Check out this #Tweetorial on
viability to see how!
...To revasc or not to revasc...
1st we need to know if the myocardium is dead or alive?! Check out this #Tweetorial on

In this #tweetorial, we will explore:
1) The spectrum of myocardial responses to ischemia (stunning, hibernation, necrosis)
2) The goals of viability testing
3) Several modalities we can use to assess for myocardial viability
4) The data behind viability testing
1) The spectrum of myocardial responses to ischemia (stunning, hibernation, necrosis)
2) The goals of viability testing
3) Several modalities we can use to assess for myocardial viability
4) The data behind viability testing
I feel comfortable in my understanding of myocardial hibernation and viability testing.
If:
LVEF is ↓
w/hypokinesis/akinesis
& FIXED perfusion deficits
--> then the myocardium is either dead (scarred), stunned, or hibernating!
LVEF is ↓
w/hypokinesis/akinesis
& FIXED perfusion deficits
--> then the myocardium is either dead (scarred), stunned, or hibernating!
This is a spectrum. Along the spectrum are intracellular adaptations that affect the contractile apparatus so that phenotypically, that region of myocardium appears hypokinetic or akinetic.
The primary goals of viability testing are:
Identify dead myocardium that would not benefit from revascularization
Identify patients whose LV systolic function may
w/ revascularization
To potentially improve survival




As mentioned in @cardionerds Ep #102, myocardial viability modalities either assess for...
“Signs of life” (e.g., evidence of inducible contractility, cell membrane integrity, metabolic activity)
“Signs of death” (e.g., myocardial wall thinning, presence of scar)


Hibernating myocardium is a diverse phenotype! The dynamic nature of the disease process and the lack of a unifying definitions have made it difficult for clinical trials to show that re-establishing myocardial blood flow to hibernating myocardium is beneficial.
As Dr. Jaber adapted from Anna Karenina, “All normal hearts are normal in the same way, & all abnormal hearts are abnormal in different ways.”
It follows that there are notable studies that have assessed the benefit of myocardial viability testing prior to revascularization:
It follows that there are notable studies that have assessed the benefit of myocardial viability testing prior to revascularization:
Viability testing is not appropriate in all settings, as it would not change mgmt in pts with:
Non-obstructive dz
Obstructive epicardial coronary dz NOT amenable to revascularization
Normal LV systolic function



In summary:
Myocardial response to ischemia is a dynamic spectrum from
stunning
hibernation
necrosis
The goals of viability testing are to identify patients who may benefit from revascularization of hibernating or stunned myocardium
Myocardial response to ischemia is a dynamic spectrum from





The goals of viability testing are to identify patients who may benefit from revascularization of hibernating or stunned myocardium
In summary (cont.):
There are numerous imaging modalities available for the evaluation of
viability.
FDG-PET and CMR +/- Dobutamine Stress are the most sensitive and specific (the attached graphic shows CMR LGE assessment of infarct transmurality)
There are numerous imaging modalities available for the evaluation of

FDG-PET and CMR +/- Dobutamine Stress are the most sensitive and specific (the attached graphic shows CMR LGE assessment of infarct transmurality)
Check out the ACC Expert Opinion from @rblument1 @GarimaVSharmaMD and the AHA Scientific Statement from @CoronaryDoc @bonowr @RonBlankstein on myocardial viability! And be sure to check out the @cardionerds Ep #102!
https://www.acc.org/latest-in-cardiology/articles/2020/08/14/07/44/non-invasive-assessment-of-myocardial-viability
https://ahajournals.org/doi/10.1161/HCI.0000000000000053
https://www.acc.org/latest-in-cardiology/articles/2020/08/14/07/44/non-invasive-assessment-of-myocardial-viability
https://ahajournals.org/doi/10.1161/HCI.0000000000000053
I feel comfortable in my understanding of myocardial hibernation and viability testing.
I learned something in this Tweetorial that may change my clinical practice.
Many thanks to @ThomasMDas and @AmitGoyalMD for their feedback and assistance with this Tweetorial!
Let me know what you think!
Let me know what you think!
@cardionerds Episode 102: Myocardial Viability--check it out!
https://www.cardionerds.com/102-nuclear-and-multimodality-imaging-myocardial-viability/
https://www.cardionerds.com/102-nuclear-and-multimodality-imaging-myocardial-viability/